Welcome to Current Partnering – life science intelligence for deal makers

We are the publisher of CP Reports – life science deal term reports. We also produce Current Agreements – the leading comprehensive partnering, M&A, financing and company database.

In addition, we offer CP Insight – an interactive platform for an advanced level of deal making intelligence, and CP Knowledge Centre – our 3-in-1 life science intelligence package – ideal for users who need comprehensive access to all that Current Partnering has to offer.

New report

Provides comprehensive understanding and unprecedented access to the  clinical stage partnering agreements deals and agreements entered into by the worlds leading healthcare companies. More

 

Featured partnering deals

Merck and Sun Pharma inks phama licensing for psoriasis treatment

September 18, 2014 : big pharma, Merck, pharma licensing

Merck & Co and Sun Pharmaceutical Industries announced an exclusive worldwide pharma licensing agreement for Merck’s investigational therapeutic antibody candidate, tildrakizumab.

more »

Myokardia forms pharma partnership with Sanofi for Cardiomyopathy

September 18, 2014 : big pharma, partnering, pharma licensing, pharma partnering, pharma partners, Sanofi

Sanofi forms pharma partnership with MyoKardia on a $200 million initiative to develop new therapies to help treat deadly genetic heart muscle disease. more »

 More partnering deals | all deals at Deal Monitor


Featured M&A deals

Denovo Biopharma has acquired enzastaurin from Eli Lilly

September 18, 2014 : acquisition, asset purchase, Eli Lilly, M&A

Denovo Biopharma has acquired enzastaurin, a late-stage oncology drug, from Eli Lilly and Company. more »

Nobel Biocare has been acquired by Danaher

September 16, 2014 : acquisition, M&A

Danaher has acquired Nobel Biocare for $2.2 billion.  more »

 More M&A deals | all deals at Deal Monitor

Featured financing deals

Avinger aims to raise $48.9 million in private placement financing

September 17, 2014 : financing, financings

Avinger has raised $34.8 million toward a $48.9 million financing target. more »

NeuroDerm files for $250 million in IPO financing

September 17, 2014 : financing, financings, ipo

NeuroDerm has filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission for a proposed initial public offering of its ordinary shares. more »

 More financing deals | all deals at Deal Monitor

Latest Dealtalk

Akorn to bid for an acquisition of UCB’s subsidiary

September 15, 2014 : acquisition, dealtalk, M&A

Akorn targets UCB’s subsidiary for acquisition for tax inversion.  more »

Orphan diseases partnering: A lucrative step for drug makers

September 2, 2014 : M&A, orphan diseases, partnering

By Shamini Thiagarajan

Increased collaborations, big pharma involvements, venture capital investments, and medical/technological breakthroughs are together changing the landscape of research and development in orphan diseases. more »

 More dealtalk

Featured reports

Discovery Stage Partnering Terms and Agreements

Publication date: September 2014

Preclinical Stage Partnering Terms and Agreements

Publication date: September 2014

Co-development Terms and Agreements

Publication date: August 2014

Personalized Medicine in Oncology Partnering Terms and Agreements

Publication date: August 2014

Licensing Terms and Agreements

Publication date: August 2014

Diagnostic Imaging Partnering Terms and Agreements

Publication date: August 2014

Trends in Therapeutic Partnering

Publication date: August 2014

Cancer Monoclonal Antibody Terms and Agreements

Publication date: August 2014

Monoclonal Antibody Terms and Agreements

Publication date: August 2014

Co-promotion & Co-marketing Partnering Terms and Agreements

Publication date: July 2014

Drug Delivery Terms and Agreements

Publication date: July 2014

Vaccine Partnering Terms and Agreements

Publication date: July 2014

Distribution Partnering Terms and Agreements

Publication date: July 2014

Diagnostics Partnering Terms and Agreements

Publication date: July 2014

Pharma and Biotech M&A Trends 2009-2014

Publication date: July 2014

NEW: Therapy deal reports covering all major indications

Including partnering in oncology, cardiovascular, CNS, metabolic, dermatology, dental, infectives, immunologypsychiatry, genitourinary.....plus many others

View all reports

Scorecard

Current Partnering provides access to key deal metrics for all leading partnering, M&A and financings - plus big pharma partnering activity and R&D spend metrics.

Available scorecards:

Partnering

M&A

Financing

Top 50 pharma partnering

Top 50 biotech partnering

Top pharma R&D spend

Deal metrics - by stage of development, therapy area, industry sector

Print Friendly
cpbannerad300x150new1gif
RSS Feed Linked In Twitter

Latest Tweets

cpbannerad300x150new2gif
2014-pmr-eur-banner-300x150gif
biospain-banner-institucional-300x150gif